Drusen evolution affects photoreceptor IS/OS junction integrity

Article

The photoreceptor inner segment/outer segment (IS/OS) junction integrity can be affected by drusen evolution.

The photoreceptor inner segment/outer segment (IS/OS) junction integrity can be affected by drusen evolution, according to a study in Retina.

Dr Kathrin Hartmann et al., Department of Ophthalmology, University of California, California, USA, performed drusen volume raster scans through 2624 drusen in 14 eyes with clinically dry age-related macular degeneration (AMD).

All eyes were longitudinally followed up between 23 and 28 months without intervention and a total of 416 of the drusen scanned were analysed for the study.

Of the drusen studied, 20% regressed spontaneously, 51% demonstrated no change in size and 29% progressed. The mean drusen size was 63.7 ± 25.7 μm. The cross-sectional analysis of drusen morphology revealed a link between drusen size and disrupted IS/OS junction/photoreceptor integrity. The IS/OS junction integrity was intact in the drusen that regressed over time.

Drusen evolution can cause structural disruption of the IS/OS junction and after drusen regression the IS/OS junction can either restore drusen regression or artifactitiously compress it.

The abstract for this study can be found here here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.